Pentoxifylline Hydrochloride

Images are for illustration purposes only;
actual packaging may vary.

Pentoxifylline Hydrochloride is a methylxanthine derivative that acts as a hemorheologic agent, primarily used to improve blood flow and reduce blood viscosity. It enhances microcirculation and tissue oxygenation, making it beneficial in conditions characterized by impaired blood flow, such as peripheral vascular disease and intermittent claudication.

By inhibiting phosphodiesterase, Pentoxifylline Hydrochloride increases cyclic adenosine monophosphate (cAMP) levels, leading to vasodilation and improved red blood cell flexibility. This mechanism helps in reducing symptoms associated with chronic occlusive arterial diseases and can be a valuable component in compounded formulations aimed at enhancing circulatory health.

Trusted by 60,357 patients to date.

A group of faces of our past satisfied patients.

Custom made in our compounding labs.

Personalized treatment for better results.

All strengths and ingredients are tailored to your needs.

This medication is not available at retail pharmacies. It is compounded, and may be more effective at treating you or your patient.

This is some text inside of a div block.

Heading 1

Heading 2

Heading 3

Heading 4

Heading 5

Heading 6

Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat. Duis aute irure dolor in reprehenderit in voluptate velit esse cillum dolore eu fugiat nulla pariatur.

Block quote

Ordered list

Item 1
Item 2
Item 3

Unordered list

Item A
Item B
Item C

Text link

Bold text

Emphasis

^Superscript

_Subscript

Thank you! Your submission has been received!

Oops! Something went wrong while submitting the form.

Active Ingredient Information

Pentoxifylline Hydrochloride is a methylxanthine derivative that plays a crucial role in improving blood flow and reducing blood viscosity, making it a valuable component in compounded formulations aimed at enhancing microcirculation. This API is particularly beneficial in conditions where improved blood flow can aid in symptom relief and promote healing, such as peripheral vascular disease and intermittent claudication.

By inhibiting phosphodiesterase, Pentoxifylline Hydrochloride increases cyclic adenosine monophosphate (cAMP) levels, leading to vasodilation and improved blood flow. This mechanism of action not only helps in reducing symptoms associated with poor circulation but also supports tissue oxygenation and nutrient delivery.

In addition to its vasodilatory effects, Pentoxifylline Hydrochloride exhibits anti-inflammatory properties, which can be advantageous in managing conditions with an inflammatory component. Its ability to modulate leukocyte activity and reduce cytokine production further enhances its therapeutic potential in various clinical scenarios.

Prescribers may find Pentoxifylline Hydrochloride particularly useful in personalized medicine approaches, where tailored formulations can address specific patient needs. Its versatility and efficacy make it a preferred choice in compounding pharmacies for creating customized treatments that optimize patient outcomes.

Formulas using

Pentoxifylline Hydrochloride

Formulas and/or material listed are not to be interpreted as a promise, guarantee or claim of therapeutic efficacy or safety. The information contained herein is not intended to replace or substitute for conventional medical care, or encourage its abandonment. Every patient is unique, and formulas should be adjusted to meet their individual needs.

No compounded medications are reviewed by the FDA for safety or efficacy.